Skip to main content

Table 1 Characteristics of patients registered in the Calmette Hospital Cohort and included in the study compared with those of non included patients (maintained in peritoneal dialysis less than 54 months)

From: No increase in small-solute transport in peritoneal dialysis patients treated without hypertonic glucose for fifty-four months

 

Missing data

(%)

Included patients

(n = 44)

Non included patients

(PD < 54 months) (n = 243)

Age (years)a

0

55.8 (13.3)

55.9 (18.8)

Gender (% men)

0

45.5%

57.2%

Diabetes (%)

0

22.7%

27.6%

Albumin (g/L)a

18.1

37.4 (3.4)

35.4 (4.7)*

C-reactive protein (mg/L)b

5.0

3 [0–10]

3 [0–9.5]

Diuresis (L/24 h)a

4.5

1.31 (0.76)

1.31 (0.72)

Renal clearance of urea (mL/min/1,73 m2)b

5.4

3.7 [2.2–4.7]

3.3 [1.8–5.0]

Renal clearance of creatinin (mL/min/1,73 m2)b

5.4

7.2 [3.9–9.5]

7.2 [3.7–10.3]

D4/D0 a

18.1

0.278 (0.071)

0.288 (0.072)

Peritoneal clearance of urea (L/week)a

5.0

46.0 (11.6)

47.6 (11.3)

Peritoneal clearance of creatinin (L/week)a

5.0

38.8 (9.4)

38.2 (10.5)

  1. PD peritoneal dialysis, SD Standard Deviation, IQR Interquartile range, D 4 /D 0 ratio of peritoneal glucose concentrations at 4-h dwell time to peritoneal glucose concentrations at 0-h dwell time;
  2. adata expressed as mean (SD) – bdata expressed as median [IQR]
  3. *P < .001